Comparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMR

Clinical trial NCT03737136 · COMPLETED

Trial details

NCT number: NCT03737136
Sponsor: Shahid Beheshti University of Medical Sciences
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Antibody-mediated Rejection

Start date: 2019-11-01
Primary completion: 2024-05-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.